Literature DB >> 16449974

Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency.

C J Lynch1, J Milner.   

Abstract

A haploid genotype may be insufficient to support normal wild-type function. Such haplo-insufficiency has recently been documented for numerous tumour suppressor genes. p53 is a crucial tumour suppressor governing DNA repair, cell cycle arrest and apoptosis via its role as a stress-responsive transcription factor. p53 haplo-insufficiency has been observed in vivo with human familial cancer in Li-Fraumeni Syndrome (LFS) and in mouse p53-knockout models of LFS. The increased tumorigenesis associated with loss of one p53 allele has been attributed to reduced p53-dependent stress responses. However, the underlying biochemical basis for such attenuated responses in p53+/- cells remains unclear. Here we have determined basal p53 messenger RNA (mRNA) and protein levels, and compared the p53 stress response in p53+/+, p53+/- and p53-/- isogenic clones derived from HCT116 cells. Basal expression of p53 in p53+/- cells was 25% relative to p53+/+ cells, and this differential was maintained following oncogenic stress. This deficiency was manifested at both p53 mRNA and protein levels and resulted in attenuated p53 stress responses, in particular for p21waf1 upregulation and survivin downregulation, and reduced G1 arrest and apoptosis. These observations identify a molecular basis for wild-type p53 haplo-insufficiency, which may explain the attenuated tumour-suppressive phenotype observed in cells with a single wild-type p53 allele and in humans with LFS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449974     DOI: 10.1038/sj.onc.1209387

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice.

Authors:  Hong Shen-Li; Susan Koujak; Matthias Szablocs; Ramon Parsons
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

Review 2.  A continuum model for tumour suppression.

Authors:  Alice H Berger; Alfred G Knudson; Pier Paolo Pandolfi
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

Review 3.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

4.  The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element.

Authors:  Anna Vilborg; Jacob A Glahder; Margareta T Wilhelm; Cinzia Bersani; Martin Corcoran; Salah Mahmoudi; Maiken Rosenstierne; Dan Grandér; Marianne Farnebo; Bodil Norrild; Klas G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-01       Impact factor: 11.205

5.  The molecular mechanism and potential role of heat shock-induced p53 protein accumulation.

Authors:  Juqiang Han; Xiaojie Xu; Hongzhen Qin; Anheng Liu; Zhongyi Fan; Lei Kang; Jing Fu; Jiahong Liu; Qinong Ye
Journal:  Mol Cell Biochem       Date:  2013-03-02       Impact factor: 3.396

6.  Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53.

Authors:  Z-G Shi; S-Q Li; Z-J Li; X-J Zhu; P Xu; G Liu
Journal:  Clin Transl Oncol       Date:  2014-07-16       Impact factor: 3.405

7.  CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation.

Authors:  David M Burns; Joel D Richter
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

8.  A new stochastic and state space model of human colon cancer incorporating multiple pathways.

Authors:  Wai Y Tan; Xiao W Yan
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

9.  SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.

Authors:  Cian J Lynch; Zahid H Shah; Simon J Allison; Shafiq U Ahmed; Jack Ford; Lorna J Warnock; Han Li; Manuel Serrano; Jo Milner
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.

Authors:  Marcia I Dawson; Zebin Xia; Gang Liu; Mao Ye; Joseph A Fontana; Lulu Farhana; Bhamik B Patel; Sankari Arumugarajah; Mohammad Bhuiyan; Xiao-Kun Zhang; Young-Hoon Han; William B Stallcup; Jun-ichi Fukushi; Tomas Mustelin; Lutz Tautz; Ying Su; Danni L Harris; Nahid Waleh; Peter D Hobbs; Ling Jong; Wan-Ru Chao; Leonard J Schiff; Brahma P Sani
Journal:  J Med Chem       Date:  2007-05-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.